USD10
Acciones de VKTX
Acerca de Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
USD10
Acciones de VKTX
Acerca de Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Estadísticas
VENTANA DE TRADING
Cerrado
ABRE A LAS
No hay datos suficientes
CAP. DE MERCADO
3755,53 M US$
PRECIO DE APERTURA
33,62 US$
MÍNIMO (1 A)
18,92 US$
MÁXIMO (1 A)
43,15 US$
MÍNIMO (24 h)
31,49 US$
MÁXIMO (24 h)
34,38 US$
VOLUMEN (24 h)
3,53 M US$
81,89 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 33,62 US$ | |
1 día | 32,33 US$ | |
1 semana | 36,62 US$ | |
1 mes | 30,34 US$ | |
1 año | 29,28 US$ |